AASLD interview of experts on new guidance for managing chronic hepatitis C and guidelines for hepatitis B.
Make the elimination of viral hepatitis our next greatest achievement.
If you are thinking of starting hepatitis C treatment, you may find the following information resources helpful.
The 194 member states of the 69th World Health Assembly have unanimously adopted the Global Viral Hepatitis Strategy to eliminate viral hepatitis by 2030, signalling the greatest global commitment on viral hepatitis ever.
As China comes to grips with fallout from its vaccine scandal, the implications, if any, for the Chinese Australian community are yet to be assessed.
Pharmaceutical company AbbVie has announced that their hepatitis C treatment Viekira Pak will be available on the Pharmaceutical Benefits Scheme (PBS) from 1 May.
So you're mentally prepared to start treatment. But what if your GP isn't? Or your local pharmacist is not set up to fill your script?
The European Medicines Agency (EMA) is reviewing six hepatitis C direct acting anti-virals (DAA) for possible hepatitis B re-activation in people with co-infection receiving hepatitis C treatment.
People getting their viral hepatitis medicines from community pharmacies appear to be encountering delays due to "system issues".
The Federal Government's billion dollar investment in new hepatitis C medicines must be supported by a concerted effort to raise public awareness of the ground-breaking treatments, experts say.
Got questions about the new hepatitis C treatments? Get your answers at Hepatitis SA's community forum.